Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Operating Leases (2019 - 2025)

SRx Health Solutions (SRXH) has disclosed Operating Leases for 7 consecutive years, with $5000.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Operating Leases fell 90.38% year-over-year to $5000.0, compared with a TTM value of $5000.0 through Mar 2025, down 90.38%, and an annual FY2024 reading of $5000.0, down 92.54% over the prior year.
  • Operating Leases was $5000.0 for Q1 2025 at SRx Health Solutions, roughly flat from $5000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $5.6 million in Q3 2024 and bottomed at $5000.0 in Q4 2021.
  • Average Operating Leases over 5 years is $435733.3, with a median of $67000.0 recorded in 2023.
  • The sharpest move saw Operating Leases tumbled 97.28% in 2021, then surged 6757.32% in 2024.
  • Year by year, Operating Leases stood at $5000.0 in 2021, then surged by 2380.0% to $124000.0 in 2022, then crashed by 45.97% to $67000.0 in 2023, then crashed by 92.54% to $5000.0 in 2024, then changed by 0.0% to $5000.0 in 2025.
  • Business Quant data shows Operating Leases for SRXH at $5000.0 in Q1 2025, $5000.0 in Q4 2024, and $5.6 million in Q3 2024.